Evaluation of medicinal herbs as a potential therapeutic option against SARS‐CoV ‐2 targeting its main protease

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

(2020) Jasper Fuk-Woo Chan et al.   LANCET

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors

(2020) Ping Li et al.   Frontiers in Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Liver injury during highly pathogenic human coronavirus infections

(2020) Ling Xu et al.   LIVER INTERNATIONAL

Potential Applications of Plant Biotechnology against SARS-CoV-2

(2020) Teresa Capell et al.   TRENDS IN PLANT SCIENCE

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

(2020) Kai Liu et al.   JOURNAL OF INFECTION

Evaluation of medicinal herbs for Anti-CHIKV activity.

(2019) Siva Raghavendhar et al.   VIROLOGY

Evaluation of green tea extract as a safe personal hygiene against viral infections

(2018) Yun Ha Lee et al.   Journal of Biological Engineering

The Drug Repurposing Hub: a next-generation drug library and information resource

(2017) Steven M Corsello et al.   NATURE MEDICINE

Antiviral effects of green tea (Camellia sinensis) against pathogenic viruses in human and animals (a mini-review)

(2016) Muhammad Shahid Mahmood et al.   African Journal of Traditional Complementary and Alternative Medicines

The green tea molecule EGCG inhibits Zika virus entry

(2016) Bruno M. Carneiro et al.   VIROLOGY

Preventive Effects of a Major Component of Green Tea, Epigallocathechin-3-Gallate, on Hepatitis-B Virus DNA Replication

(2015) Murat Karamese et al.   Asian Pacific Journal of Cancer Prevention

From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

(2014) Rolf Hilgenfeld   FEBS Journal